Biolex Acquires Epicyte Pharmaceutical
Combination creates powerful monoclonal antibodies capabilities
07-May-2004 -
Pittsboro, N.C. -- Biolex, Inc., a privately held
protein therapeutics company, has acquired Epicyte Pharmaceutical, Inc.,
a privately held, San Diego-based company focused on the discovery and
development of human monoclonal antibodies (mAbs). The combination
creates powerful mAbs capabilities ...
antibodies
drug development
monoclonal antibodies
+3